Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

INBP

Integrated BioPharma, Inc.

USD

Set alert

Price alert · INBP

All alert types
0.17 USD 0.00 0.00%
As of Oct 30, 2026
0.165 Day range 0.165
0.15 52-week range 0.38
YTD
-52.78%
1 year
-43.33%
Open
0.165
Prev close
0.17
Mkt cap
5.28M
Vol
16.49K
Avg vol
8.76K
EPS
-0.09
P/E
0.00
More statistics
Low
0.165
High
0.165

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for INBP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.45 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -2.0×
FY 2017: 1.7×FY 2018: 6.9×FY 2019: 3.2×FY 2020: 3.2×FY 2021: 4.1×FY 2022: 3.8×FY 2023: -300×FY 2024: 54.1×FY 2025: 13.4×FY 2026: -2.0×
FY 2017 5y median 3.8× FY 2026
P/S 0.1×
FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.3×FY 2021: 0.5×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.2×FY 2026: 0.1×
FY 2017 5y median 0.2× FY 2026
P/B 0.3×
FY 2017: -0.7×FY 2018: -0.9×FY 2019: 2.8×FY 2020: 2.2×FY 2021: 2.3×FY 2022: 0.8×FY 2023: 0.5×FY 2024: 0.3×FY 2025: 0.5×FY 2026: 0.3×
FY 2017 5y median 0.5× FY 2026
P/FCF 6.2×
FY 2017: 57.3×FY 2018: 5.1×FY 2019: -62.2×FY 2020: 11.8×FY 2021: 11.9×FY 2022: 4.1×FY 2023: 8.9×FY 2024: 15.4×FY 2025: 5.8×FY 2026: 6.2×
FY 2017 5y median 6.2× FY 2026
EV/EBITDA -3.2×
FY 2017: 5.3×FY 2018: 8.3×FY 2019: 5.1×FY 2020: 5.6×FY 2021: 5.6×FY 2022: 4.7×FY 2023: 8.8×FY 2024: 4.2×FY 2025: 2.4×FY 2026: -3.2×
FY 2017 5y median 4.2× FY 2026
EV/Sales 0.1×
FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 0.6×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.2×FY 2026: 0.1×
FY 2017 5y median 0.2× FY 2026
FCF Yield 16.0%
FY 2017: 1.7%FY 2018: 19.6%FY 2019: -1.6%FY 2020: 8.5%FY 2021: 8.4%FY 2022: 24.2%FY 2023: 11.3%FY 2024: 6.5%FY 2025: 17.3%FY 2026: 16.0%
FY 2017 5y median 16.0% FY 2026

Profitability

Gross Margin 1.8%
FY 2017: 14.2%FY 2018: 11.4%FY 2019: 12.4%FY 2020: 12.7%FY 2021: 14.9%FY 2022: 11.6%FY 2023: 8.0%FY 2024: 7.7%FY 2025: 10.2%FY 2026: 1.8%
FY 2017 5y median 8.0% FY 2026
Operating Margin -6.2%
FY 2017: 6.8%FY 2018: 3.9%FY 2019: 5.4%FY 2020: 4.5%FY 2021: 9.1%FY 2022: 3.5%FY 2023: 0.2%FY 2024: 0.5%FY 2025: 3.7%FY 2026: -6.2%
FY 2017 5y median 0.5% FY 2026
Net Margin -6.5%
FY 2017: 5.0%FY 2018: 1.6%FY 2019: 3.4%FY 2020: 7.8%FY 2021: 12.6%FY 2022: 6.8%FY 2023: -0.1%FY 2024: 0.2%FY 2025: 1.5%FY 2026: -6.5%
FY 2017 5y median 0.2% FY 2026
ROE -16.1%
FY 2017: -39.6%FY 2018: -13.0%FY 2019: 89.2%FY 2020: 67.7%FY 2021: 55.9%FY 2022: 20.7%FY 2023: -0.2%FY 2024: 0.6%FY 2025: 4.0%FY 2026: -16.1%
FY 2017 5y median 0.6% FY 2026
ROIC -13.0%
FY 2017: 32.4%FY 2018: 12.3%FY 2019: 15.1%FY 2020: 13.9%FY 2021: 31.0%FY 2022: 9.5%FY 2023: -0.2%FY 2024: 0.5%FY 2025: 3.7%FY 2026: -13.0%
FY 2017 5y median 0.5% FY 2026
ROA -11.2%
FY 2017: 15.4%FY 2018: 4.7%FY 2019: 8.5%FY 2020: 17.9%FY 2021: 31.5%FY 2022: 15.2%FY 2023: -0.1%FY 2024: 0.4%FY 2025: 3.2%FY 2026: -11.2%
FY 2017 5y median 0.4% FY 2026

Growth (YoY)

Revenue -19.3%
FY 2017: 11.2%FY 2018: -6.9%FY 2019: 14.3%FY 2020: 5.6%FY 2021: 20.4%FY 2022: -11.5%FY 2023: -9.9%FY 2024: -0.7%FY 2025: 8.0%FY 2026: -19.3%
FY 2017 FY 2026
Operating Income -233.9%
FY 2017: 50.8%FY 2018: -46.8%FY 2019: 59.6%FY 2020: -11.8%FY 2021: 142.6%FY 2022: -66.0%FY 2023: -93.9%FY 2024: 109.2%FY 2025: 704.8%FY 2026: -233.9%
FY 2017 FY 2026
EPS (diluted) -453.3%
FY 2017: 100.0%FY 2018: -77.6%FY 2019: 154.9%FY 2020: 127.7%FY 2021: 92.3%FY 2022: -52.0%FY 2023: -100.9%FY 2024: 427.3%FY 2025: 619.4%FY 2026: -453.3%
FY 2017 FY 2026
Free Cash Flow -52.2%
FY 2017: 110.0%FY 2018: 1215.7%FY 2019: -109.3%FY 2020: 1408.1%FY 2021: 144.9%FY 2022: 30.9%FY 2023: -69.0%FY 2024: -65.1%FY 2025: 380.5%FY 2026: -52.2%
FY 2017 FY 2026

Financial Health

Current Ratio 3.0×
FY 2017: 1.1×FY 2018: 0.8×FY 2019: 1.1×FY 2020: 1.3×FY 2021: 1.9×FY 2022: 3.2×FY 2023: 3.4×FY 2024: 2.9×FY 2025: 4.4×FY 2026: 3.0×
FY 2017 5y median 3.2× FY 2026
Quick Ratio 1.4×
FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 0.7×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 2.2×FY 2026: 1.4×
FY 2017 5y median 1.3× FY 2026
Debt / Equity 0.2×
FY 2017: -2.6×FY 2018: -2.8×FY 2019: 6.8×FY 2020: 1.8×FY 2021: 0.3×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.2×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 1.1×
FY 2017: 4.2×FY 2018: 6.3×FY 2019: 3.6×FY 2020: 2.5×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 1.1×FY 2024: 0.1×FY 2025: -0.8×FY 2026: 1.1×
FY 2017 5y median 0.5× FY 2026
Interest Coverage -225×
FY 2017: 3.5×FY 2018: 1.8×FY 2019: 4.3×FY 2020: 6.0×FY 2021: 22.6×FY 2022: 15.4×FY 2023: 3.0×FY 2024: 4.8×FY 2025: 43.9×FY 2026: -225×
FY 2017 5y median 4.8× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30